1. Misdiagnosing recurrent medulloblastoma: the danger of examination and imaging without histological confirmation
- Author
-
Ilana Friedman, Adam S. Levy, Lauren Weintraub, Todd S. Miller, and Rick Abbott
- Subjects
medicine.medical_specialty ,Vomiting ,Radiography ,Vision Disorders ,Antineoplastic Agents ,Dexamethasone ,Diagnosis, Differential ,Treatment Refusal ,medicine ,Recurrent disease ,Humans ,Diagnostic Errors ,Cerebellar Neoplasms ,Child ,Fatigue ,Medulloblastoma ,medicine.diagnostic_test ,business.industry ,Palliative Care ,Headache ,Magnetic resonance imaging ,General Medicine ,Recurrent Medulloblastoma ,medicine.disease ,Complete resolution ,Magnetic Resonance Imaging ,Treatment Outcome ,Female ,Radiology ,Neoplasm Recurrence, Local ,business ,Tomography, X-Ray Computed - Abstract
The screening and detection of recurrent medulloblastoma presents the clinician with significant diagnostic challenges, including the risk of misdiagnosis. The authors present the case of a young girl with a history of a treated standard-risk medulloblastoma that highlights the risk of assuming recurrence has occurred when clinical and/or imaging changes are observed. This girl developed both new clinical deficits and had radiographic evidence of recurrence. She subsequently experienced a complete resolution of symptoms and radiographic findings with steroids alone.
- Published
- 2013